London based health tech startup secures $11m investment
A UK and US health tech startup has announced that it has secured $11m of funding.
Quit Genius, which has its UK headquarters in London, has received the investment from a Series A funding round led by Octopus Ventures.
Hubert Burda Media’s international growth capital arm BurdaPrincipal Investments joined the round along with Y Combinator, Startup Health, and Triple Point Ventures.
The company uses cognitive behavioural therapy aims to aid users in quitting smoking and vaping tobacco products.
Quit Genius is expected to use the funding to expand into other types of addiction, including alcohol and opioid addiction.
Amelia Townsend, principal at BurdaPrincipal Investments, commented: “At BPI we are working in-depth into the health tech space.
“We are delighted to join the Quit Genius team and our fellow investors and are looking forward to being part of the journey!”
Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular morning London email for free.
Raising the bar to boost North East growth
Navigating the messy middle of business growth
We must make it easier to hire young people
Why community-based care is key to NHS' future
Culture, confidence and creativity in the North East
Putting in the groundwork to boost skills
£100,000 milestone drives forward STEM work
Restoring confidence for the economic road ahead
Ready to scale? Buy-and-build offers opportunity
When will our regional economy grow?
Creating a thriving North East construction sector
Why investors are still backing the North East